Stem Cell Therapy in Hypoxic Ischemic Encephalopathy
Authors
Abstract:
Introduction there are one million deaths from asphyxia in newborn annually. Management of this newborn is only supportive. Autologuse stem cell therapy may reduce mortality and long term morbidity. Outcome of asphyxiated newborn is related to damage CNS cells. Stem cells prevent Apoptosis and induce repairmen of injured neurons. Methods in a review study all article related to three keywords of stem cell, newborn, hypoxic ischemic encephalopathy (HIE) were studied. Results in study of Paula et al stem cell by release of trophic factors and inflammatory mediators had supportive effect on HIE. In another experimental study (in mice) the authors observed improvement in sensorial and motors function and decreasing ischemic lesion. Veltron et al in 9 mice with HIE, injection of stem cell from nose 10 days after asphyxia found improvement in gray mater (34%) and white mater (37%). they also found secretion of some growth factor such as FGP2, NGFT in case group. Moa et al in an experimental study observed increasing of neurons and increased IQ in 6 months of age. Conclusion Recent studies showed that stem cells will improve CNS function by reducing damaged lesion. Keywords: Hypoxic Ischemic encephalopathy, Newborn, Stem cell.
similar resources
stem cell therapy in hypoxic ischemic encephalopathy
introduction there are one million deaths from asphyxia in newborn annually. management of this newborn is only supportive. autologuse stem cell therapy may reduce mortality and long term morbidity. outcome of asphyxiated newborn is related to damage cns cells. stem cells prevent apoptosis and induce repairmen of injured neurons. methods in a review study all article related to three keywords o...
full textStem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy
Treatments for neonatal hypoxic-ischemic encephalopathy (HIE) have been limited. The aim of this paper is to offer translational research guidance on stem cell therapy for neonatal HIE by examining clinically relevant animal models, practical stem cell sources, safety and efficacy of endpoint assays, as well as a general understanding of modes of action of this cellular therapy. In order to do ...
full textPreterm Hypoxic–Ischemic Encephalopathy
Hypoxic-ischemic encephalopathy (HIE) is a recognizable and defined clinical syndrome in term infants that results from a severe or prolonged hypoxic-ischemic episode before or during birth. However, in the preterm infant, defining hypoxic-ischemic injury (HII), its clinical course, monitoring, and outcomes remains complex. Few studies examine preterm HIE, and these are heterogeneous, with vari...
full textPerinatal Hypoxic-Ischemic Encephalopathy
Perinatal hypoxic-ischemic encephalopathy (HIE) is an important cause of brain injury in the newborn and can result in long-term devastating consequences. Perinatal hypoxia is a vital cause of long-term neurologic complications varying from mild behavioural deficits to severe seizure, mental retardation, and/or cerebral palsy in the newborn. In the mammalian developing brain, ongoing research i...
full textHypoxic-Ischemic Encephalopathy Biomarkers
Background Clinical RS for HIE are intended to determine trial entry and to compare groups within or between trials. Categorical current schemes do not reflect the broad clinical continuum spectrum of HIE and they were not design for this task. Objective To prospectively validate a new structured multi-item RS for HIE. Methods A standardised structured ordinal RS for HIE with 7 clinical items (...
full textHypoxic ischemic encephalopathy in neonates.
BACKGROUND Birth anoxia remains an important cause of mortality and morbidity in neonates. Hypoxia/ischemia can lead to permanent brain damage and also affects other tissues of the body. It results from lack of oxygen before, during or after birth. The study was designed to assess the risk factors of birth asphyxia, common presentations and association of Apgar score with grades of hypoxic-isch...
full textMy Resources
Journal title
volume 2 issue 2.3
pages 60- 60
publication date 2014-05-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023